In addition to the most advanced single-use bioreactors, we now provide world-class process development and scale-up services
|
Vertical-Wheel™ Bioreactor Product Family
Our line of innovative single-use bioreactors can provide homogeneous, low-shear, and scalable mixing across a wide range of working volumes
|
Contract Research and Process Development Services
With unmatched expertise in process development for a variety of cell therapy applications, we can fulfill your research and manufacturing scale-up needs
|
Current Job Opportunities
Recent Publications, Posters, and Blogs
2020 July 8 - Bioengineering, volume 7, issue 3:
Lembong et al., Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel
System
2020 Jun. 13 - Journal of Visualized Experiments, issue 160:
Silva et al., Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by
Immunostaining
2020 May 7 - ISCT conference virtual presentation:
Lembong et al., Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel
System
2020 Jun. 13 - Journal of Visualized Experiments, issue 160:
Silva et al., Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by
Immunostaining
2020 May 7 - ISCT conference virtual presentation:
2020 May 4 - Genetic Engineering and Biotechnology News article:
Roberts, Josh P., Fast Tracking Cell Therapy Manufacturing Across Borders
2020 Mar. 28 - Bioengineering publication (in press):
Lee et al., Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
2020 Jan. 22 - Phacilitate conference poster and Phacilitate:Exchange Cell and Gene Therapy blog posts:
Jung et al., Super Scalability and Robustness of Cell Therapy Manufacturing Using Vertical-Wheel Bioreactors
Blog post #2: Maximising the Yield and Quality of iPSC-Derived Therapeutic Products
Blog post #1: Innovations for Scalable Manufacturing of Allogeneic Cell Therapy Products
2019 Sep. 14 - Journal of Biological Engineering, volume 13, article 74:
Nogueira et al., Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-
Wheel™ bioreactors
2019 Jan. 27 - ECI Advancing Manufacture of Cell and Gene Therapies VI conference posters:
Borys et al., Computational Fluid Dynamics (CFD) Modeling of Single-Use, Vertical-Wheel Bioreactors as a Predictive Scale-up Tool
for Large Scale Stem Cell Culture (best poster winner)
Croughan et al., Engineering Characterization of a Versatile Vertical-Wheel Bioreactor for Cell and Gene Therapy
See more in our Resource Center
Roberts, Josh P., Fast Tracking Cell Therapy Manufacturing Across Borders
2020 Mar. 28 - Bioengineering publication (in press):
Lee et al., Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
2020 Jan. 22 - Phacilitate conference poster and Phacilitate:Exchange Cell and Gene Therapy blog posts:
Jung et al., Super Scalability and Robustness of Cell Therapy Manufacturing Using Vertical-Wheel Bioreactors
Blog post #2: Maximising the Yield and Quality of iPSC-Derived Therapeutic Products
Blog post #1: Innovations for Scalable Manufacturing of Allogeneic Cell Therapy Products
2019 Sep. 14 - Journal of Biological Engineering, volume 13, article 74:
Nogueira et al., Strategies for the expansion of human induced pluripotent stem cells as aggregates in single-use Vertical-
Wheel™ bioreactors
2019 Jan. 27 - ECI Advancing Manufacture of Cell and Gene Therapies VI conference posters:
Borys et al., Computational Fluid Dynamics (CFD) Modeling of Single-Use, Vertical-Wheel Bioreactors as a Predictive Scale-up Tool
for Large Scale Stem Cell Culture (best poster winner)
Croughan et al., Engineering Characterization of a Versatile Vertical-Wheel Bioreactor for Cell and Gene Therapy
See more in our Resource Center
Upcoming Conferences and Exhibitions
Note: participation in future conferences contingent on COVID-19 situation
Note: participation in future conferences contingent on COVID-19 situation